Today: 20 July 2026
RELX share price slides to 2,215p as buyback rolls on; April update in focus
24 February 2026
1 min read

RELX share price slides to 2,215p as buyback rolls on; April update in focus

London, February 24, 2026, 08:20 GMT — Regular session

  • RELX slipped roughly 1.6% in early London action.
  • Late Monday, the company revealed a new round of share buybacks.
  • Investors are zeroed in on April 23, when the company’s next trading update and AGM are scheduled.

RELX dropped 1.6% to 2,215 pence early Tuesday, trading close to the lower end of the 2,210–2,248p band after finishing at 2,251p the previous session.

The British information group disclosed Monday it picked up 800,000 shares on the London Stock Exchange via UBS, paying anywhere from 2,248p up to 2,326p per share. The average price, weighted by volume, landed at 2,272.614p. According to the filing, the shares will go into the company’s treasury—kept on the books, not cancelled.

Buybacks aren’t meant to steal the spotlight, but that’s what’s happening. Lately, investors have zeroed in on daily repurchase lines, using them as a crude gauge of management’s view on the stock’s lower bound — and whether that level actually sticks.

Risk sentiment has wobbled, as fresh trade concerns resurfaced following U.S. President Donald Trump’s suggestion of a 15% temporary tariff on imports. That’s held UK stocks in check as the new week gets underway.

Following a steep derating amid concerns over AI’s impact on demand, RELX is shifting focus back to its products and what it sees as enduring pricing power. In its annual results earlier this month, RELX pointed to “embedded AI” as a growth engine for years ahead. Chief Financial Officer Nick Luff told Reuters the company’s “comprehensive data and content” sets it apart. Reuters

It’s not just RELX facing these concerns. Wolters Kluwer and Thomson Reuters, too, have found themselves caught up in the same questions: as generative AI starts weaving into the day-to-day work of professionals, which products end up as commodities, and which ones keep their edge?

The near-term setup remains tangled. Buybacks might help manage supply, sure, but they’re no guarantee—fresh buyers aren’t showing up if the next numbers miss, or if sentiment on AI shifts back to worry over disruption.

April 23 is the next key date: RELX will issue a trading update for the 2026 financial year and hold its annual general meeting. Shareholders are also watching May 7, the ex-dividend date for the final payout, with half-year results to follow on July 23.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Scott Pape Urges Australians Not to Panic Over Super Withdrawals Despite Grantham's Market Crash Alert
    July 19, 2026, 8:13 PM EDT. Scott Pape, known as the Barefoot Investor, advises Australians to avoid making hasty decisions about withdrawing their superannuation or selling out of Australian and US index funds after billionaire Jeremy Grantham's warnings of a possible US market crash. Grantham, whose firm oversees $78bn and who previously called the dot-com and 2007 housing crashes, has stated US equities are "badly overpriced" and has described the AI surge as the largest investment bubble in US history. While Pape acknowledges that US stocks could be overvalued and calls crypto "mostly worthless," he encourages investors to remain with their portfolios. He points out that long-term share investing has delivered the highest returns despite short-term fluctuations, and he notes that it is very difficult to time buying and selling, referencing that Grantham has been wary about the markets since 2021.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

USA Rare Earth (USAR) stock slips in premarket after 9% jump — what to watch next
Next Story

USA Rare Earth (USAR) stock slips in premarket after 9% jump — what to watch next

Go toTop